Neuron23 uncloaks with $113.5M to tackle CNS disorders through genetic mutations
Since October 2018, scientists at Neuron23 have worked quietly to find their place in the world of precision medicine. That place is using artificial intelligence and data science to target neurodegenerative and neuroinflammatory diseases in patients with specific genetic mutations.